Brief: MediciNova Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Fibrosis In Korea
27/07/2022 11:57
July 27 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT
COVERING
MN-001 AND MN-002 FOR THE TREATMENT OF FIBROSIS IN KOREA
Source text for Eikon: ID:nGNXb2C86t
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake